Ursodiol Tablets 01
Ursodiol
Product Images NDC 0591-2998
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 0591-2998). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ursodiol Tablets 02
NDC 0591-2998-01 is a prescription drug called Ursodiol, which is available in tablet form. The tablets are manufactured and distributed by Contabiaboratories and Actavis. Each tablet contains 250mg of Ursodiol, and the recommended adult dosage is 13-15 mg per kilogram per day in two to four divided doses with food. This drug should only be dispensed in a tight container and kept out of reach of children. For more information, please refer to the package insert. Store at a temperature between 20°C to 25°C (68°F to 77°F).*
Ursodiol Tablets 03
This is a medication description for Ursodiol tablets, USP, which are used for the treatment of Primary Biliary Cirrhosis. The tablets are scored and come in a container with 100 tablets. The recommended dosage is 13-15 mg/kg/day in two to four divided doses with food. The tablets should be stored at 20°C to 25°C (68°F to 77°F) in a tight container. The manufacturer is Confab Laboratories in St-Hubert (Québec) CANADA, and it is distributed by Actavis Pharma, Inc in Parsippany, USA. The text also includes information about dispensing the tablets and keeping them out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
